Weybosset Research & Management LLC Amgen Inc Transaction History

Weybosset Research & Management LLC

$295 Million
Q3 2024

A detailed history of Weybosset Research & Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Weybosset Research & Management LLC holds 700 shares of AMGN stock, worth $196,007. This represents 0.08% of its overall portfolio holdings.

Number of Shares

700

Previous 650 7.69%

Holding current value

$196,007

Previous $203,000 11.33%

% of portfolio

0.08%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$309.38 - $337.38 $15,469 - $16,869	50 Added 7.69%	700 $226,000
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $170,787 - $207,551	650 New	650 $203,000
Q4 2023 Jan 18, 2024	BUY	$255.7 - $288.46 $178,990 - $201,922	700 New	700 $201,000
Q4 2022 Feb 16, 2023	SELL	$229.03 - $291.01 $91,612 - $116,404	-400 Reduced 21.62%	1,450 $381,000
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $89,784 - $101,260	400 Added 27.59%	1,850 $417,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $80,748 - $89,859	-350 Reduced 19.44%	1,450 $353,000
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $34,804 - $39,830	175 Added 10.77%	1,800 $405,000
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $15,920 - $18,652	75 Added 4.84%	1,625 $346,000
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $5,839 - $6,478	-25 Reduced 1.59%	1,550 $378,000
Q4 2020 Jan 21, 2021	SELL	$216.38 - $257.67 $32,457 - $38,650	-150 Reduced 8.7%	1,575 $362,000
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $27,336 - $36,255	-150 Reduced 8.0%	1,725 $343,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $354,768 - $456,000	1,875 New	1,875 $452,000
Q3 2019 Oct 22, 2019	SELL	$174.11 - $208.62 $326,456 - $391,162	-1,875 Closed	0 $0
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $36,174 - $40,776	200 Added 11.94%	1,875 $356,000
Q4 2018 Jan 25, 2019	SELL	$178.4 - $208.25 $8,920 - $10,412	-50 Reduced 2.9%	1,675 $326,000
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $13,896 - $15,666	75 Added 4.55%	1,725 $358,000
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $278,503 - $311,173	1,650	1,650 $287,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weybosset Research & Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weybosset Research & Management LLC with notifications on news.

Account

Weybosset Research & Management LLC Amgen Inc Transaction History